XOMA Co. (NASDAQ:XOMAO – Get Free Report) saw a significant decline in short interest in December. As of December 31st, there was short interest totaling 9,148 shares, a decline of 21.2% from the December 15th total of 11,615 shares. Based on an average daily trading volume, of 2,126 shares, the short-interest ratio is currently 4.3 days. Based on an average daily trading volume, of 2,126 shares, the short-interest ratio is currently 4.3 days.
XOMA Trading Down 0.1%
Shares of NASDAQ:XOMAO opened at $25.32 on Monday. XOMA has a 1 year low of $23.32 and a 1 year high of $25.76. The business’s 50 day moving average price is $25.42 and its 200-day moving average price is $25.44.
About XOMA
XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.
In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.
Featured Stories
- Five stocks we like better than XOMA
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
